Location History:
- Osaka, JP (2019)
- Ikoma, JP (2009 - 2021)
Company Filing History:
18 out of 281 
1 out of 2 Years Active: 2009-2021
Title: Kenji Kawashima: Innovator in Pharmaceutical Patents
Introduction
Kenji Kawashima, based in Ikoma, Japan, is an accomplished inventor with a remarkable portfolio of 19 patents. His innovative contributions primarily revolve around pharmaceutical compounds, showcasing his significant impact in the field of medicinal chemistry.
Latest Patents
Among his latest inventions, Kawashima developed a compound known as 6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative. This compound exhibits BRD4 inhibitory activity, positioning it as a potential therapeutic agent for diseases associated with BRD4. Another notable patent includes the development of a [4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or its salts. This innovation holds glucocorticoid receptor agonist activity, making it a valuable candidate for treating glucocorticoid receptor-related diseases.
Career Highlights
Kawashima has made significant strides in the pharmaceutical industry, having worked with esteemed companies such as Santen Pharmaceutical Co., Ltd. and Ayumi Pharmaceutical Corporation. His contributions within these organizations have been instrumental in advancing medicinal research and drug development.
Collaborations
Throughout his career, Kawashima has collaborated with other notable figures such as Minoru Yamamoto and Takahiro Honda. These partnerships highlight the collaborative nature of innovation in the pharmaceutical sector, where sharing knowledge and expertise can lead to groundbreaking advancements.
Conclusion
Kenji Kawashima’s innovative spirit and dedication to research have positioned him as a leading inventor in the pharmaceutical field. With a strong portfolio of patents and significant collaborations, he continues to contribute to the advancement of medicinal science, demonstrating the essential role of inventors in improving healthcare.